InvestorsHub Logo
Followers 20
Posts 1930
Boards Moderated 0
Alias Born 03/21/2010

Re: Biobillionair post# 292410

Sunday, 08/23/2020 1:32:02 PM

Sunday, August 23, 2020 1:32:02 PM

Post# of 425931
If Amarin does decide to introduce a generic version of Vascepa, will they find a cheaper way to manufacture it (and have an inferior product as a result) or will they find some marketing advantage to say their product, even as a generic, is superior to what's being offered by the other generics?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News